Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-053707
Filing Date
2025-04-14
Accepted
2025-04-14 16:07:43
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-14

Document Format Files

Seq Description Document Type Size
1 ARS kytx_2024_asr_annual_rep.pdf ARS 4575719
  Complete submission text file 0000950170-25-053707.txt   6303494
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41947 | Film No.: 25836101
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)